Featured Research

from universities, journals, and other organizations

Antioxidants May Protect Against Tick-borne Illness

Date:
August 9, 2006
Source:
University of Rochester Medical Center
Summary:
For hikers, campers and others who enjoy the outdoors, summer can bring concerns about tick bites and related illnesses such as Rocky Mountain spotted fever. Researchers are investigating the role that antioxidants -- alpha-lipoic acid and potentially others like green tea and vitamins C and E, for example -- might play in preventing or treating the deadly rickettsia bacteria.

For hikers, campers and others who enjoy the outdoors, summer can bring concerns about tick bites and related illnesses such as Rocky Mountain spotted fever. Researchers are investigating the role that antioxidants -- alpha-lipoic acid and potentially others like green tea and vitamins C and E, for example -- might play in preventing or treating the deadly rickettsia bacteria.

The National Institute of Allergy and Infectious Disease, part of the National Institutes of Health, awarded the University of Rochester Medical Center $2 million for a five-year study of the antioxidant theory. The grant caps more than a decade of rickettsia research led by Sanjeev Sahni, Ph.D.

Rocky Mountain spotted fever is the most frequently reported illness in the United States caused by the rickettsia bacteria, which is transmitted by tick parasites. It usually afflicts otherwise healthy adults and children who are bitten by wood ticks or dog ticks. The illness can become life threatening if left untreated, and spotted fever can be difficult for physicians to diagnose because the earliest signs mimic less-serious viral illnesses. Limiting exposure to ticks is the best way to prevent the disease. If it does develop, in most cases doctors can treat it with antibiotics. Typhus is another rickettsial disease spread by lice or fleas. Although less common, typhus remains a threat in crowded jails and in other poor hygienic environments.

"Our studies have the potential to identify novel therapeutic targets for a host of rickettsial diseases," said Sahni, an assistant professor in Hematology/Oncology at the University of Rochester.

Dr. Howard Taylor Ricketts, who eventually died of typhus, identified rickettsia in the late 1800s. Sahni's research group first began investigating the rickettsia bacteria as a model to study the biological changes that occur in the lining of the blood vessels (endothelium) as the bacteria travels through the blood stream. Initially they were looking at what types of cellular changes occur in response to the infection. They discovered that cells undergo oxidative stress and produce harmful free radicals, causing inflammation and other complications.

Researchers hypothesized that antioxidants might serve as useful therapies after examining the damage to infected cells, as seen by electron microscopy, and through biochemical evidence proving oxidative stress (OS), a term used to describe a level of damage in cells, tissue and organs. Antioxidants can generally neutralize free radicals and reduce oxidative damage. Earlier experiments in which scientists infected cells with rickettsia bacteria and then treated the cells with alpha-lipoic acid, a powerful antioxidant, showed that the infected cells did, indeed, marshal a defense against the bacteria.

Sahni is also investigating what enzymes might boost antioxidants to work more efficiently. His group is studying the process that occurs when infected cells express cyclooxygenase (Cox-2) and prostaglandins, which results in inflammation. This biological process is what causes the severe swelling in the limb that was bitten by a tick harboring the rickettsia bacteria. Sahni theorizes that regulating the Cox-2 response with Cox-2 inhibitors such as ibuprofen could also help control the disease.

The University of Rochester team is collaborating with David J. Silverman, Ph.D., of the University of Maryland.


Story Source:

The above story is based on materials provided by University of Rochester Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Rochester Medical Center. "Antioxidants May Protect Against Tick-borne Illness." ScienceDaily. ScienceDaily, 9 August 2006. <www.sciencedaily.com/releases/2006/08/060809232944.htm>.
University of Rochester Medical Center. (2006, August 9). Antioxidants May Protect Against Tick-borne Illness. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2006/08/060809232944.htm
University of Rochester Medical Center. "Antioxidants May Protect Against Tick-borne Illness." ScienceDaily. www.sciencedaily.com/releases/2006/08/060809232944.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins